On Feb 2, 2027
View on KalshiGLP-1 / GLP
Dazodalibep
VESALIUS-CV
Eosinophilic
Medicare
Imfinzi / Durvalumab
ESMO
Artificial Intelligence (3+ times)
Patent (2+ times)
Tavneos
Acquisition
Litigation
Oral (3+ times)
Prolia (2+ times)
Buyback / Buy Back
No pending strikes yet. Sign in to suggest one.
Upvote the picks you think will hit. Add your own. Build ELO when Jake posts them to Kalshi.